von Haehling, Stephan
Assmus, Birgit
Bekfani, Tarek
Dworatzek, Elke
Edelmann, Frank
Hashemi, Djawid
Hellenkamp, Kristian
Kempf, Tibor
Raake, Philipp
Schütt, Katharina A.
Wachter, Rolf
Schulze, Paul Christian
Hasenfuss, Gerd
Böhm, Michael
Bauersachs, Johann
Funding for this research was provided by:
Georg-August-Universität Göttingen
Article History
Received: 5 December 2023
Accepted: 2 February 2024
First Online: 11 April 2024
Declarations
:
: S.v.H. has been a paid consultant for and/or received honoraria payments from Amomed, AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Edwards Lifesciences, MSD, Novo Nordisk, Novartis, Pfizer, Pharmacosmos, Respicardia, Roche, Servier, Sorin, and Vifor. S.v.H. reports research support from Amgen, AstraZeneca, Boehringer Ingelheim, Pharmacosmos, IMI, and the German Center for Cardiovascular Research (DZHK). B.A. has been a paid consultant for and/or received honoraria payments from Abbott, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Edwards Lifesciences, Novartis, Novonordisk, Pfizer, Vifor, and ZOLL. B.A. reports research support from the German Research Foundation (SFB 1213, project B09), and the German Innovations Funds (GBA). T.B. has been a paid consultant for and/or received honoraria payments from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Sanofi, Takeda, and Vifor. F.E. reports speaker and/or consultant honoraria from AstraZeneca, Novartis, Böhringer Ingelheim, Servier, Bayer, Merck, Vifor, Berlin Chemie, and PharmaCosmos. F.E. reports research grants from DFG, BMBF, DZHK, AstraZeneca, and Servier. D.H. has been the recipient of two grants issued by DZHK (Grant Number, 81X3100214 and Grant Number, 81X3100220). D.H. has been paid consultancy and speaking fees by several pharmaceutical companies, namely AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, and Vifor. D.H. is participant in the BIH Charité Digital Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin, and the Berlin Institute of Health at Charité (BIH). K.H. received speaker and/or consultant honoraria from AstraZeneca, Bayer, BDI, Boehringer Ingelheim, and Novartis. K.H. received travel grants and/or congress fees from Abbott, Bayer, and EuroPCR. K.H. reports research support from AstraZeneca. T.K. has been a paid consultant for and/or received honoraria payments from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Edwards, Endotronix, Norgine, Novartis, Medtronic, Pharmacosmos, Roche Diagnostics, and Vifor. P.R. reports speaker and/or consultant honoraria from Edwards, Medtronic, Abbott, Biotronik, AstraZeneca, Novartis, Bayer, Vifor, Daiichi-Sankyo, CTI GmbH, Diaplan, Elisabeth-KH Essen, Conventus Congressmanagement Jena, BDI, CMI Medizinische Ausstellungs- und Werbegesellschaft Wien, Herzzentrum Leipzig, Leipzig Heart Institute GmbH, Kelcon, and Deutsche Gesellschaft für Kardiologie. P.R. reports research grants from Pfizer and Else-Kröner-Fresenius-Stiftung. K.A.S. has been a paid consultant for and/or received honoraria payments from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, MSD, Novo Nordisk, and Novartis. K.A.S. is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TRR 219; Project-ID 322900939 [C-07]). R.W. has been a paid consultant for and/or received honoraria payments from AstraZeneca, Bayer, BMS, Boehringer Ingelheim, CVRx, Daiichi, Medtronic, Novartis, Pfizer, Pharmacosmos, and Servier. R.W. reports research support from Boehringer Ingelheim, Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, European Union, Medtronic, and the German Center for Cardiovascular Research (DZHK). P.C.S. received honoraria for lectures/consulting from Novartis, Vifor, Bayer, Pfizer, Boehringer Ingelheim, AstraZeneca, Cardior, BMS, Abiomed, Pharmacosmos, and Amgen not related to this article. P.C.S. reports research support for the department from Boehringer Ingelheim, Edwards, and Abiomed not related to this article. G.H. has been a paid consultant for and/or received honoraria payments from AstraZeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Corvia, Impulse Dynamics, Novartis, Pfizer, Servier, Springer, G. Thieme, and Vifor. M.B. is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322 900 939) and reports personal fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Recor, Servier, and Vifor. J.B. received honoraria for lectures/consulting from Novartis, Vifor, Bayer, Pfizer, Boehringer Ingelheim, AstraZeneca, Cardior, CVRx, BMS, Amgen, Corvia, Norgine, and Roche not related to this article; and research support for the department from Zoll, CVRx, Abiomed, Norgine, and Roche, not related to this article. All other authors do not have a conflict of interest relevant to this article.